Literature DB >> 24962698

Continuous Infragluteal Sciatic Nerve Block for Postoperative Pain Control After Total Ankle Arthroplasty.

Diana Starr Young1, Adam Cota2, Ruth Chaytor1.   

Abstract

Continuous peripheral nerve blocks (CPNB) for postoperative pain control are being used more frequently for total ankle arthroplasty. The purpose of this study was to compare the amount of opioid analgesia used in patients with an infragluteal CPNB to that of patients with no CPNB for postoperative pain management after total ankle replacement. A retrospective cohort study was performed on 78 consecutive patients who had a total ankle arthroplasty from October 2006 to June 2013. The primary outcome measure was opioid analgesia use in the first 48 hours postoperatively. The mean postoperative narcotic use in oral morphine equivalents was 64.6 mg in the CPNB group compared to 129.6 mg in the no CPNB group (P < .001). Using an infragluteal CPNB as a means of postoperative pain control in patients undergoing a total ankle replacement is associated with significantly decreased opioid use compared to patients receiving no CPNB. LEVELS OF EVIDENCE: Therapeutic, Level IV, case series.
© 2014 The Author(s).

Entities:  

Keywords:  ankle arthroplasty; continuous infusion; infragluteal block; regional anesthesia; surgery

Year:  2014        PMID: 24962698     DOI: 10.1177/1938640014537303

Source DB:  PubMed          Journal:  Foot Ankle Spec        ISSN: 1938-6400


  2 in total

1.  Efficacy of Sciatic Nerve Block for Pain Management in below Knee Orthopaedic Surgery.

Authors:  Subhadra Arun Sinha; Sandeep Champalal Mutha; Deepak Sadashiv Phalgune
Journal:  J Clin Diagn Res       Date:  2016-09-01

2.  Peripheral nerve block use in ankle arthroplasty and ankle arthrodesis: utilization patterns and impact on outcomes.

Authors:  Jimmy J Chan; Evan Garden; Jesse C Chan; Jashvant Poeran; Nicole Zubizarreta; Madhu Mazumdar; Leesa M Galatz; Ettore Vulcano
Journal:  J Anesth       Date:  2021-09-04       Impact factor: 2.078

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.